专利信息

查询条件展开筛选条件

[药品] 包含 'Roxithromycin'

首页 1 2 3 4 5 6 下页尾页共 202 条记录, 当前第1/21页。

	公开号	公开日	申请号	申请日

首页 1 2 3 4 5 6 下页尾页共 202 条记录, 当前第1/21页。

当前查询条件: [药品] 包含 'Roxithromycin'

	查询范围	在当前结果中查询
!	专利类型	发明实用新型外观设计
!	公开号			CN1234
!	申请号			CN1234
!	专利标题		扩展	PHARMA
!	专利权人		扩展	pfizer
	发明人
!	申请日			yyyymmdd
!	公开日			yyyymmdd
	优先权号
!	摘要		扩展	PHARMA
	IPC			A01B

1. CN101862303B	2014/3/19	CN2009182159	2009/4/17
专利标题：Roxithromycin sustained release tablets and preparation method thereof 专利权人：Beijing Yiling Bioengineering Co., Ltd.;

2. CN102516336B	2014/2/19	CN20111395415	2011/12/3
专利标题：Roxithromycin impurity j and preparation method thereof 专利权人：Hec Pharm Co., Ltd.;

3. CN103536547A	2014/1/29	CN20131481515	2013/10/15
专利标题：Injection roxithromycin composite freeze-dried powder 专利权人：

4. CN103505404A	2014/1/15	CN20131415702	2013/9/12
专利标题：A kind ofly take the oral liquid that roxithromycin is active component 专利权人：

5. CN102286045B	2013/8/7	CN20111262939	2011/9/7
专利标题：Roxithromycin hydrate crystallization, its preparation method and contain this crystallization and the composition dry suspensoid of ambroxol hcl combination 专利权人：Shandong Luoxin Pharmacy Stock Co., Ltd.;

6. CN102358749B	2013/7/24	CN20111332016	2011/10/27
专利标题：A kind of roxithromycin and ambroxol hydrochloride tablet composition and preparation method thereof 专利权人：Shandong Luoxin Pharmacy Stock Co., Ltd.;

7. CN103130853A	2013/6/5	CN20121551885	2008/10/6
专利标题：Roxithromycin crystal c type material, method for making and pharmaceutical composition and purposes 专利权人：Institute Of Materia Medica, Chinese Academy Of Medical Sciences;

8. CN103083278A	2013/5/8	CN20111345107	2011/11/4
专利标题：Roxithromycin capsule and preparation method thereof 专利权人：Sichuan Kelun Pharmaceutical Research Co., Ltd.;

9. US2013102550A1	2013/4/25	US201113640643	2011/4/14
专利标题：AMORPHOUS ROXITHROMYCIN COMPOSITION 专利权人：LIEBENBERG WILNA [ZA];AUCAMP MARIQUE [ZA];UNIV NORTHWEST [ZA]; This invention relates to a macrolide composition, more particularly an amorphous form (Form-III) of 3R, 4S, 5S, 6R, 7R, 9R, 11S, 12R, 13S, 14R-6-[(2S, 3R, 4S, 6R)-4-dimethylamino-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7, 12, 13-trihydroxy-4-[(2R, 4R, 5S, 6S)-5-hydroxy-4-methoxy-4, 6-dimethyloxan-2-yl]oxy-10-(2-methoxyethoxymethoxy-imino)-3, 5, 7, 9, 11, 13-hexamethyl-1-oxacyclotetradecan-2-one or roxithromycin characterised by the absence of peaks in the infra-red spectrum of amorphous (Form-...

10. US20130102550A1	2013/4/25	US13/640643	2011/4/14
专利标题：Amorphous roxithromycin composition 专利权人：North-west University; This invention relates to a macrolide composition more particularly an amorphous form (Form-III) of 3R 4S 5S 6R 7R 9R 11S 12R 13S 14R-6-[(2S 3R 4S 6R)-4-dimethylamino-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7 12 13-trihydroxy-4-[(2R 4R 5S 6S)-5-hydroxy-4-methoxy-4 6-dimethyloxan-2-yl]oxy-10-(2-methoxyethoxymethoxy-imino)-3 5 7 9 11 13-hexamethyl-1-oxacyclotetradecan-2-one or roxithromycin characterised by the absence of peaks in the infra-red spectrum of amorphous (Form-III) of roxithromycin at...

下载范围

下载内容